Prednisone Recruiting Phase 2 Trials for Autoimmune Disorders / Autoimmune Diseases Treatment

RecruitingTreatment2 IdentifierTitleDrugs
NCT00716066Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy
NCT02458196Study of Treatment Response on IgG4 Related Disease (IgG4RD)